Skip to Content
Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

Idex Ends 2020 on a Solid Note; Raising Fair Value

Analyst Note

| Krzysztof Smalec, CFA |

Narrow-moat-rated Idex reported strong fourth-quarter results, as its sales of $615 million and adjusted EPS of $1.37 both came in ahead of FactSet consensus estimates of $602 million and $1.31, respectively. After rolling our model forward one year, we’ve raised our fair value estimate for the cash compounder to $196 from $190, which reflects solid performance, an improving outlook, and time value of money. We see shares as fairly valued at current levels.

Read Full Analysis

Company Profile

Business Description

Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire & safety, life science, and water. The firm’s business is organized into three segments: fluid & metering technologies, health & science technologies, and fire & safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has 7,000 employees. The company generated $2.4 billion in revenue and $537 million in adjusted operating income in 2020.

Contact
3100 Sanders Road, Suite 301
Chicago, IL, 60062
T +1 847 498-7070
Sector Industrials
Industry Specialty Industrial Machinery
Most Recent Earnings Dec 31, 2020
Fiscal Year End Dec 31, 2021
Stock Type Cyclical
Employees 7,075